Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.46%
1,098.97
-5.13
-0.46%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.54%
607.45
+3.29
+0.54%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.33%
1,193.89
-3.92
-0.33%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.26%
1,735.85
-4.56
-0.26%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.66%
638.65
+4.21
+0.66%
634.44633.13639.67633.01
SIXR
Staples
SIXR
Staples
SIXR
-0.76%
834.53
-6.37
-0.76%
840.90839.53841.73834.56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.41%
214.25
-0.88
-0.41%
215.13215.13215.85213.99
SIXT
Technology
SIXT
Technology
SIXT
-0.34%
3,217.73
-10.98
-0.34%
3,228.713,225.623,227.743,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
937.12
+1.25
+0.13%
935.87938.37942.00937.00
SIXV
Health care
SIXV
Health care
SIXV
-0.16%
1,454.83
-2.29
-0.16%
1,457.121,452.741,466.881,449.55
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.50%
2,387.89
-11.95
-0.50%
2,399.842,389.712,392.302,371.22
CVKD:NASDAQ
Cadrenal Therapeutics Inc
$5.61
+2.00%
(+0.11) 1D
Apr 27, 12:54:33 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CVKD...
Open
$5.57
High
$5.80
Low
$5.51
Mkt. cap
14.06M
Avg. vol.
48.23K
Volume
26.51K
52-wk high
$17.50
52-wk low
$4.21
EPS
-$6.64
Beta
1.53
Shares outstanding
2.51M
No. of employees
5
News stories
From sources across the web
Stock Traders Daily
Stock Traders Daily
·
22 hours ago
Understanding the Setup: (CVKD) and Scalable Risk
About Cadrenal Therapeutics Inc
CEO-
Employees5
Founded2022
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.67M
1.08M
688.46K
666.32K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.25M
2.66M
2.04M
2.40M
Operating expense
3.93M
3.73M
2.73M
3.07M
Total operating expenses
3.93M
3.73M
2.73M
3.07M
Operating income
-3.93M
-3.73M
-2.73M
-3.07M
Other non operating income
-
-
-
-
EBT including unusual items
-3.85M
-3.67M
-2.69M
-3.04M
EBT excluding unusual items
-3.85M
-3.67M
-2.69M
-3.04M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.85M
-3.67M
-2.69M
-3.04M
Net profit margin
-
-
-
-
Earnings per share
-2.09
-1.87
-1.31
-1.41
Interest and investment income
82.60K
67.00K
48.10K
26.12K
Interest expense
-
-
-
-
Net interest expenses
82.60K
67.00K
48.10K
26.12K
Depreciation and amortization charges
5.52K
401.00
401.00
555.00
EBITDA
-3.92M
-3.73M
-2.73M
-3.06M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more